Abstract:
A testing apparatus using hypersonic flow is provided to form hypersonic flow or high-temperature flow field by using shock wave in order to reproduce actual hypersonic flow and high-temperature flow field. A testing apparatus using hypersonic flow is comprised of a shock wave generator, a nozzle, a testing chamber and a dump tank. The shock wave generator(10) generates shock wave in flow. The nozzle(20) is connected to the shock wave generator to accelerate the flow flowed from the shock wave generator. The testing chamber(30) is combined with the nozzle. The hypersonic flow is supplied to the testing chamber wherein a test model of the hypersonic flow test is installed. The inner space of the dump tank is linked to the testing chamber.
Abstract:
A method of transmitting and receiving a data frame supporting a video MAC protocol and a system thereof are provided to use contents having error partially, thereby reducing waste of network resources due to contents retransmission. A video MAC(Media Access Control) support terminal determines whether a video MAC protocol is supported(S210). A video MAC data frame is received so that the video MAC support terminal determines whether error exists in a header. If the error does not exist in the header, the received video MAC data frame is provided to a user without respect to that error exists in a body(S240).
Abstract:
A motion compensation apparatus is provided to minimize a cache line with a cache address configuration and perform motion compensation without data collision, thereby decoding clearly an image. A motion compensation apparatus comprises a cache memory, an external memory, and a motion compensation engine. The cache memory comprises a save domain and an address assigning domain composed of cache lines. The external memory is comprised of a plurality of blocks in which each cache line index is given. The external memory is made of a plurality of rows. In the external memory, data of a row of an image frame is stored within one row among the plurality of rows. The motion compensation engine stores image data, stored in each block of the external memory, in a cache line which a cache line index designates. The motion compensation engine performs motion compensation with image data stored in the designated cache line.
Abstract:
An organogel is provided to ensure thermoreverible property and viscoelasticity and to have specific structure that nanofiber formed by self-assembly of gelation materials is uniformly dispersed in a gel state. An organogel compound has a structure represented by the following chemical formula (I). A method for manufacturing an organic gel compound comprises a step of reacting 4-hydroxy-4'-[6-(acryloyloxy)hexyloxy]biphenyl and a compound of the following chemical formula (II). In chemical formula (II), n is an integer of 9-13. A method for manufacturing a polymer composite inserted with nanofiber comprises a step of irradiating ultraviolet rays to the organogel formed with hexyl methacrylate and the compound of chemical formula (I) in the presence of a photoinitiator.
Abstract:
A MEK1(mitogen-activated protein kinase kinase 1) inhibitor containing RSVL2(3,5,3',4',5'-pentahydroxy-trans-stilbene) is provided to selectively inhibit MEK1 and AP-1(activator protein 1) and treat various inflammatory diseases. A MEK1 inhibitor comprises a RSVL2(3,5,3',4',5'-pentahydroxy-trans-stilbene) of the chemical formula 1 as an active ingredient. A pharmaceutical composition for preventing and treating inflammatory disease comprises 0.01-50 weight% of RSVL2. A pharmaceutical composition further comprises a pharmaceutically allowable carrier, diluents, or excipient. The daily dose of the composition is 0.1-100 mg/kg(weight). A food composition for preventing inflammatory disease comprises 0.001-50 weight% of RSVL2.
Abstract:
An anticancer composition containing a 5-deoxykaempferol is provided to inhibit the activation of matrix metalloproteinase(MMP) and the infiltration of cancer cell. An anticancer composition of 0.1-50 weight% of 5-deoxykaempferol of the chemical formula 1 an active ingredient. The anticancer comprise medicine, food, food additive, beverage, or beverage additive. The cancer is colon cancer, stomach cancer, breast cancer, and liver cancer. The anticancer composition further comprises a pharmaceutically allowable carrier, diluents, or excipient. The daily dose of anticancer composition is 0.1-100 mg/kg(body weight).
Abstract:
A method for modifying the surface of hydroxyapatite ceramics is provided to remove the soluble components such as calcium oxide, etc. generated at the surface by pyrolysis. A method for modifying the surface of hydroxyapatite ceramics comprises the steps of preparing an aqueous solution containing a phosphate ion by injecting a phosphate to water; precipitating hydroxyapatite ceramics in the phosphate aqueous solution so as to age it; washing the aged hydroxyapatite ceramics with water; and drying the washed hydroxyapatite ceramics.
Abstract:
An implant material by the anodizing and manufacturing method thereof are provided, which obtain biocompatibility, chemical compatibility, and mechanical compatibility. An implant material manufacturing method by anodizing comprises: a step of coating the implant surface in the electron-beam evaporation process which can be anodic oxidized in the surface of the implant base material; and a step that dips the implant surface in electrolyte and anodizes the implant surface. The implant base material is made of titanium, ti-alloy, stainless steel, or the Co-CR alloy.
Abstract:
A method for manufacturing an image forming body by using an imprinting process, the image forming body made by the method and an imprinting system are provided to simplify the manufacturing process by forming a plurality of ring electrodes. A method for manufacturing an image forming body by using an imprinting process comprises the following steps of: providing an image drum(120); transferring the conductive ink for plural ring electrodes on the outer circumference of the image drum by using the imprinting process; forming the ring electrodes by hardening the conductive ink; and forming an outer insulating layer on the outer circumference of the image drum.
Abstract:
A thermostable amylase mutant is provided to increase the speed of cyclodextrin to the hydrolytic speed of maltooligosaccharide. A thermostable amylase mutant has an amino acid of the sequence number 2. A polynucleotide coding the thermostable amylase mutant has a sequence of the sequence number 1. A method for producing a maltooligosaccharide is to react the thermostable amylase mutant with cyclodextrin. The cyclodextrin is one or more selected from alpha-cyclodextrin, and beta-cyclodextrin and gamma-cyclodextrin. The maltooligosaccharide is one or more selected from a group of chain maltooligosaccharide of 6-8 glucose molecules.